Plus Therapeutics (NASDAQ:PSTV) reported its Q4 earnings results on Tuesday, March 5, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Plus Therapeutics beat estimated earnings by 35.0%, reporting an EPS of $-0.7 versus an estimate of $-1.07.
Revenue was up $1.16 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.12 which was followed by a 6.0% increase in the share price the next day.
Here's a look at Plus Therapeutics's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -1.12 | -1.91 | -1.95 | -1.8 |
| EPS Actual | -1 | -0.59 | -2.10 | -2.4 |
| Revenue Estimate | 1.29M | 790K | 740K | 1.27M |
| Revenue Actual | 1.24M | 1.85M | 506K | 151K |
To track all earnings releases for Plus Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.